As the coronavirus outbreak shows, viruses are a constant threat to humanity. Vaccines are regularly developed and deployed against specific viruses, but that process takes a lot of time, doesn’t help everyone who needs protection, and still leaves people exposed to new outbreaks and new viruses.
Now, researchers at Massachusetts General Hospital (MGH) have uncovered a novel potential antiviral drug target that could lead to treatments protecting against a host of infectious diseases – creating a pan, or universal, treatment. Their work suggests that the protein Argonaute 4 (AGO4) is an “Achilles heel” for viruses.
AGO4 is one of a family of AGO proteins. Until now, there has been little evidence of whether they have individual roles. The researchers, led by Kate L. Jeffrey, PhD, and her collaborators found that AGO4 plays a key role protecting cells against viral infections.
Specifically, this protein is uniquely antiviral in mammalian immune cells. The group studied the anti-viral effects of several Argonaute proteins, and found that only cells that were deficient in AGO4 were “hyper-susceptible” to viral infection. In other words, low levels of AGO4 make mammalian cells more likely to become infected.
This study was published today by Cell Reports.
The MGH researchers suggest that boosting levels of AGO4 could shore up the immune system to protect against multiple viruses. “The goal is to understand how our immune system works so we can create treatments that work against a range of viruses, rather than just vaccines against a particular one,” says Jeffrey.
Mammals have four Argonaute proteins (1-4), which act by silencing genes and which are remarkably conserved throughout multiple living things, including plants. These are RNA interference (RNAi) and microRNA effector proteins and RNAi is the major antiviral defense strategy in plants and invertebrates. Studies of influenza infected mice have shown that AGO4-deficient animals have significantly higher levels of the virus.
The next steps are to “determine how broad spectrum this is to any virus type,” says Jeffrey. “Then we need to discover how to boost AGO4 to ramp up protection against viral infections.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Universal antiviral drug target
- Longhorn Vaccines and Diagnostics Presents New Data on its Best-In-Class Infectious Disease Vaccine and Antibody Portfolio at ECCMID 2024
LHNVD-105, a universal influenza vaccine ... The candidates presented include LHNVD-105, an adjuvanted composite peptide vaccine that targets multiple stages of the viral replication process, and a ...
- Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million
RA Capital Management with significant participation by Bain Capital Life Sciences as well as BVF Partners and Canaan Partners to fund Phase 2b clinical trial SAN DIEGO, CA, USA I April 24, 2024 I ...
- WHO Sounds Alarm on Viral Hepatitis Infections Claiming 3,500 Lives Each Day
Report shows only 3% of people with hepatitis B and 20% of those with hepatitis C have received antiviral treatment.
- WHO warns of viral Hepatitis crisis: 3,500 lives lost daily
New data from 187 countries show that the estimated number of deaths from viral hepatitis increased from 1.1 million in 2019 to 1.3 million in 2022. Of these, 83% were caused by hepatitis B, and 17% ...
- WHO sounds alarm on viral hepatitis infections that claim 3,500 lives each day
Global Hepatitis Report, the number of lives lost due to viral hepatitis is increasing. The disease is the second leading infectious cause of death globally -- with 1.3 million deaths per year, the ...
Go deeper with Google Headlines on:
Universal antiviral drug target
[google_news title=”” keyword=”universal antiviral drug target” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Viruses
- What’s Going Around: Scarlet fever, influenza, upper respiratory infections, stomach viruses, allergies
Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local doctors and hospitals.
- Respiratory viruses levels currently minimal across Illinois
The Illinois Department of Public Health reported Friday that the respiratory virus level statewide is minimal as the respiratory virus season continues to wind down.
- Early test results show pasteurized milk with traces of H5N1 virus isn’t infectious, FDA says
The US Food and Drug Administration said Tuesday that it had detected viral particles of H5N1 avian influenza in milk purchased at grocery stores, but the agency says it still believes that the milk ...
- Scientists discover higher levels of CO₂ increase survival of viruses in the air and transmission risk
A new study has revealed for the first time the vital role carbon dioxide (CO2) plays in determining the lifespan of airborne viruses—namely SARS-CoV-2, the virus that causes COVID-19. It clearly ...
- How immune cells communicate to fight viruses: New mouse model enables identification of chemokine producers and sensors
Chemokines are signaling proteins that orchestrate the interaction of immune cells against pathogens and tumors. To understand this complex network, various techniques have been developed to identify ...
Go deeper with Google Headlines on:
Viruses
[google_news title=”” keyword=”viruses ” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]